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Abstract
Objectives CD4+ CD25+ FoxP3+ T cells (Tregs) play an
essential role in sustaining self-tolerance by negatively regu-
lating immune responses. Increased frequencies of Tregs have
been reported in a variety of human cancers. The aim of this
study was to evaluate the prevalence of Tregs infiltration in the
peripheral blood and regional lymph nodes during rat tongue
carcinogenesis induced by 4-nitroquinoline-1-oxide (4NQO).
Materials and methods Forty-eight Sprague–Dawley rats
were divided into the control (n =16) and experimental groups
(n =32) to which 4NQO in drinking water was administered.
Flow cytometry was used to analyze the prevalence of Tregs
in lymphocytes of peripheral blood and regional lymph nodes
during 4NQO-induced rat tongue carcinogenesis. CD4+
CD25+ FoxP3+ cells were expressed as a percentage of the
total CD4+ cells.
Results The frequency of Tregs in peripheral blood from
squamous cell carcinoma rats was significantly higher than
controls (3.82±0.62 versus 1.40±0.31 %, P <0.001). The
proportion of Tregs was sequentially increased frommoderate
dysplasia to severe dysplasia and SCC (1.94±0.72, 2.29±
0.82, and 3.82±0.62 %, respectively). The frequency of Tregs
in regional lymph nodes from squamous cell carcinoma rats
was also significantly higher than normal rat mucosa (14.67±
3.09 versus 5.53±2.07%, P <0.001). The percentage of Tregs
was gradually increased in moderate dysplasia, severe dyspla-
sia, and SCC groups (8.93±1.74, 10.15±0.86, 14.67±3.09%,
respectively) as compared to control group (5.53±2.07 %).
Conclusion and clinical relevance Tregs in peripheral blood
and lymph nodes were associated with disease progression
during 4NQO-induced rat tongue carcinogenesis. This study
indicated that the upregulation of Tregs might play important
role during oral mucosa malignant transformation.
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Introduction
Oral squamous cell carcinoma (OSCC) is the most common
oral malignancy with a high propensity to local recurrence,
most commonly in the regional lymph node. Despite recent
advances in therapy, the 5-year survival rate of OSCC has
remained at approximately 50 % [1]. The development of oral
cancer is usually preceded by the appearance of premalignant
lesions which have the potential to develop into cancer [2].
The mechanisms involved in the transformation of
premalignant/ potentially malignant lesions to invasive cancer
remain largely unknown. Therefore, improving our knowl-
edge about the precise molecular mechanisms involved in oral
mucosa tumorigenesis from premalignant lesions to invasive
squamous cell carcinoma is critical to develop new treatment
strategies for OSCC.
It is increasingly realized that the host immune system also
plays a pivotal role in oral carcinogenesis apart from various
factors including tobacco, alcohol, viral infection, and physi-
cal irritation [3]. CD4+ CD25+ Foxp3+ regulatory T cells
(Tregs) are a unique subset of CD4+ T cells characterized by
specific expression of CD25 (the α-chain of the receptor for
interleukin-2) and the transcription factor forkhead box pro-
tein P3 (Foxp3) [4]. There is accumulating evidence that Tregs
play an important role in the suppression of antitumor immune
responses [5, 6]. Several recent studies have reported that
increase population of Tregs in peripheral blood, draining
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lymph nodes, and tumor microenvironment in various cancer
patients, including gastric, lung, breast, colorectal, and head
and neck squamous cell carcinoma [7–10]. Furthermore, the
increase of Tregs is likely to correlate with poor outcome and
reduced survival in these cancer patients [11–13]. Gasparoto
et al. [14] reported that Tregs were increased in blood and
primary tumors of OSCC patients, and these cells appeared to
suppress immune responses. These studies demonstrated that
Tregs exerted immune suppressive function in tumor progres-
sion. However, until now, no report focuses on the distribution
of Tregs during multi-step process of oral carcinogenesis.
To explore the role of Tregs and their correlation with
multistage carcinogenesis, a good experimental model of 4-
nitroquinoline 1-oxide (4NQO)-induced tongue carcinogene-
sis was used. The rat tongue carcinoma induced by water-
soluble 4NQO closely mimics all carcinogenesis stages of
their human counterparts from various degrees of epithelial
dysplasia to carcinoma, which provides an ideal model for
understanding how neoplasm develops [15].
In the current study, we investigated the distribution of
CD4+ CD25+ Foxp3+ Tregs in the peripheral blood and
regional lymph node lymphocytes during 4NQO-induced rat




4NQO obtained from Sigma-Aldrich (St. Louis, MO, USA)
was dissolved in distilled water, as stock solution (500 ppm),
and diluted in the drinking water to a final concentration of
25 ppm.
Experimental model
All animal experiments were carried out according to the
guidelines of the Committee on Experimental Animals of
Sun Yat-sen University (SYU), PR of China. We purchased
forty-eight Sprague–Dawley (SD) rats (6 weeks old; 90–95 g)
from the Animal Experimental Center of SYU. The animals
were maintained under specific pathogen-free conditions of
temperature (24±2 °C), light–dark periods of 12 h. The ani-
mals were randomly assigned to three groups (n =16 rats per
group). In the experimental groups, rats were daily fed with
distilled water containing 25 ppm 4NQO for 16 or 24 weeks,
whereas animals in the control group were fed with distilled
water only. At the end of the experimental period, the rats
were anesthetized using isoflurane, and blood was collected
by cardiac puncture using BD vacutainer vials containing
EDTA. All neck lymph nodes of a reasonable size were
harvested in each group. Blood and lymph node samples were
sent to a central FACS laboratory and were analyzed for the
presence of regulatory T cells. The tongue tissues were col-
lected and longitudinally separated bisected for histopatholog-
ical examination. The tissue was fixed in 10 % buffered
formalin and stained with hematoxylin and eosin (H.E.,
Merck, Darmstadt, Germany).
Histopathological examination
For each experimental rat, both the visible lesion and clinical-
ly normal adjacent mucosa on the tongue were collected.
Histopathological evaluation was performed by two experi-
enced oral pathologists in a double-blind manner. Analyses of
the tongue specimens were graded as normal epithelium, mild
dysplasia, moderate dysplasia, severe dysplasia, and carcino-
ma, basically according to the criteria described by Kramer
et al. [16].
Isolation of peripheral blood mononuclear cells
Rat peripheral blood was collected in heparinized tubes and
diluted with equal fresh sterile phosphate-buffered saline
(PBS). Peripheral blood mononuclear cells (PBMCs) were
isolated using Ficoll-Hypaque (eBioscience, San Diego,
USA) density gradient centrifugation, washed, and counted.
Viability of PBMCs was determined by a trypan blue dye and
immediately used for experiments.
Preparation of lymph node lymphocytes
Lymph nodes were harvested from 4NQO-induced rats and
control rats. A single-cell suspension was prepared from the
lymph node within 1 h after excision. Tissues were first
washed with PBS and cut into 3–5 mm pieces and then
disaggregated mechanically into single-cells by a
Medimachine (DAKO, Hamburg, Germany). Then, the
lymph node suspensions were lysed with FACSTM Lysing
Solution (BD Biosciences) for 10 min at room temperature
in the dark. After erythrocyte lysis, cells were washed with
PBS and counted in a trypan blue dye. The cell concentration
was adjusted to 2×107/mL.
Flow cytometry analysis
The following antibodies were used for flow cytometry: anti-
CD4-FITC and anti-CD4-PE; anti-Foxp3-APC and their re-
spective isotypes were purchased from eBioscience (San
Diego, USA). The PBMCs or lymph node lymphocytes were
incubated with a cocktail of FITC-labeled anti-rat CD4 mono-
clonal antibody and PE-labeled anti-rat CD25 monoclonal
antibody for 30 min in the dark at 4 °C to stain the surface.
Next, cells were stained intracellularly for Foxp3 according to
the manufacturer's instructions. Briefly, cells were
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resuspended in 1 ml Foxp3 fixation/permeabilization buffer
(Fix/Perm, eBioscience) and incubated for 30 min at 4 °C in
the dark. Then, Foxp3 antibody or isotype control was added
followed by incubation for 30min at 4 °C in darkness. Finally,
cells were washed, resuspended in washing buffer, and ana-
lyzed by flow cytometry. Data were acquired on an FC500
flow cytometer (Beckman Coulter) and analyzed with CXP
software. A gate was first set on lymphocytes followed by
gating of CD4+ T cells. Within this gate, Tregs were defined
as CD4+ CD25+ Foxp3+ cells. The frequency of Foxp3+
Treg cells was shown as percent of the total CD4+
lymphocytes.
Statistical analysis
Statistical analysis was performed by using the SPSS statisti-
cal software (SPSS16.0, Chicago, USA). Data are expressed
as mean ± SEM. Quantitative densitometry values were com-
pared by Student's t test. For multiple group comparisons,
one-way ANOVAwith Tukey's post test was performed. P <
0.05 was considered significant.
Results
Histopathological evaluation following 4NQO treatment
None of the control animals developed any visible tongue
epithelia lesions and histopathological changes through the
end of the study (Fig. 1a). At 16 weeks, moderate and/or
severe dysplasia was found in the tongue (Fig. 1b, c). At
20 weeks, severe oral dysplasia and squamous cell carcinoma
(SCC) were found (Fig. 1d). The histopathological grade was
usually squamous cell carcinoma of a well-differentiated type.
The tumors spread into the submucosa and underlying muscle
layer, forming small nests with typical keratin pearl formation.
The histopathological findings are summarized in Table 1.
According to histological study, specimens were divided into
four groups: normal (n =16), moderate dysplasia (n =8), se-
vere dysplasia (n =12), and SCC (n =12).
Distribution of Tregs in rat peripheral blood
The frequency of Tregs in 4NQO-treated rat peripheral blood
as well as in the control group was evaluated by flow cytom-
etry (Fig. 2a). Tregs were identified as CD4+ CD25+ Foxp3+
cells and expressed as a percentage of the total CD4+ cells.
The CD4+ CD25+ Foxp3+ cells stepped up along with the
progression of 4NQO-induced rat tongue carcinogenesis. The
frequency of Tregs in OSCC rat was significantly higher than
control (3.82±0.62 versus 1.40±0.31 %, P <0.001). The pro-
portion of Tregs was sequentially increased from moderate
dysplasia to severe dysplasia and SCC (1.94±0.72, 2.29±
0.82, 3.82±0.62 %, respectively). Statistical differences (P <
0.001) were observed between severe dysplasia and SCC
groups. These results suggested that Tregs were related to rat
tongue squamous carcinoma progression.
Distribution of Tregs in rat lymph node
The density of Foxp3+ Tregs in rat lymph nodes was
higher than that in peripheral blood. The percent of Tregs in
rat lymph nodes increased upon the development of tongue
carcinogenesis. The frequency of Tregs was gradually
Fig. 1 Histopathology of 4-
nitroquinoline 1-oxide-induced
rat tongue carcinogenesis stained
by hematoxylin and eosin. a
Normal, b moderate dysplasia, c
severe dysplasia, d squamous cell
carcinoma. Original
magnification, ×200. Bar : 50 μM
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increased in moderate dysplasia, severe dysplasia, and SCC
groups (8.93±1.74, 10.15±0.86, 14.67±3.09, respectively) as
compared to the control group (5.53±2.07 %) (Fig. 2b). The
percentage of Tregs was significantly higher in severe dyspla-
sia and SCC rat than in control rat (P <0.001, P <0.001,
respectively). SCC rats represented higher proportion of Tregs
than those with severe dysplasia (P =0.002). No significant
statistically difference (P >0.05) was observed between the
severe dysplasia group and moderate dysplasia group
(P =0.0279).
Discussion
In the present study, we have described the sequential analysis
of CD4+ CD25+ FoxP3+ Tregs frequency in the peripheral
blood as well as lymph nodes of 4NQO-induced rat tongue
carcinogenesis. The prevalence of Tregs was gradually in-
creased in peripheral blood and regional lymph node accord-
ing to disease progression during rat tongue carcinogenesis.
Regulatory T cells play vital roles in maintaining immune
homeostasis, preventing autoimmune diseases and
diminishing antitumor immunoresponse [17]. Increasing evi-
dence demonstrated that the frequency and activity of CD4+
CD25+ FoxP3+ Tregs increased in the circulation and tumor
microenvironment in patients with various types of cancer.
The increase of Tregs was negatively correlated with tumor
progression and prognosis [18, 19]. Recent data indicated that
tumor immune response also played important role in oral
carcinogenesis. Induction of immune surveillance is often
observed in the early stage of OSCC [20]. However, the local
and systemic cell-mediated response is suppressed following
disease progression in cancer patients leading to the escape of
tumor cells [21]. So far, the exact role of Tregs in the progres-
sion of OSCC remains unclear.
In this study, we used a good rat model to explore the role
of Treg cells during oral carcinogenesis, which mimics the
multistage carcinogenesis of human OSCC on morphological
and biological concepts and allows the isolation of all stages
under controlled conditions. We found that the frequency of
Treg cells in peripheral blood was higher in squamous cell
carcinoma rat than controls. Our results are in concordance
with several previous studies in human cancer. CD4+ CD25+
Tregs from peripheral blood of OSCC patients had regulator
phenotype, with higher detection of FoxP3 [14]. Next, we
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Fig. 2 The frequency of CD4+
CD25+ Foxp3+ T cells in
peripheral blood and lymph nodes
in rats given 4NQO in drinking
water and control rats without
4NQO. a The prevalence of
CD4+ CD25+ Foxp3+ T cells in
peripheral blood was gradually
increased in 4NQO-induced rats
as compared with normal
controls. b The prevalence of
CD4+ CD25+ Foxp3+ T cells in
lymph nodes was higher in
4NQO-induced rats than normal
controls. The data are reported as
mean ± SD of three independent
experiments.*P <0.001 as
compared with control
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investigated the correlation of Tregs with tumor grades.
Our data showed that Tregs in the peripheral blood
occurred at an early stage of oral carcinogenesis and
then the infiltration of Tregs gradually increased accord-
ing to disease progression from moderate to severe oral
dysplasia and squamous cell carcinoma. It suggested
that the prevalence of circulating Tregs was significantly
correlated with the tumor grades, and it may play an
important role in oral cancer progression.
The tumor-draining lymph node is the critical initial site in
which tumor antigens are typically first presented to the naive
immune system and antitumor immune responses are initiate. It
has outsize influence on host immune response [22]. A number
of studies have identified CD4+ CD25+ Treg cells infiltration
of draining lymph node in mouse models and human cancer.
Munn et al. [23] proposed that the tumor-draining lymph node
was a unique immunological environment where the presence
of Tregs could mediate a suppressive effect on antitumor im-
mune response. Moreover, accumulation of Tregs in draining
lymph nodes was associated with poor prognosis in patients
with colorectal cancer [24]. In addition, depletion of Tregs
enhanced effector T cell responses in tumor-draining lymph
nodes [25, 26]. These studies suggested that Treg cells in lymph
nodes suppressed antitumor immune response. We questioned
whether Treg cells infiltration in lymph nodes of oral cancer
also suppress the host immune response. Our study showed that
the percentage of CD4+ CD25+ Treg cells in lymph nodes was
significantly higher from OSCC rat than in controls. Moreover,
Tregs seemed to markedly accumulate more in rat lymph nodes
than in peripheral blood. Next, we analyzed the relationship of
Tregs frequency in lymph nodes with disease progression. The
percentage of Tregs in lymph nodes was also observed to be
increased by the increase in the tumor stage from moderate to
severe oral dysplasia and squamous cell carcinoma. The nov-
elty of this studywas that Tregs was analyzed in lymph nodes in
parallel with peripheral blood. Another research in gastric can-
cer also found significant elevated Tregs in PBMCs and tumor-
draining lymph nodes [27]. These findings suggested that in-
creased Tregs in lymph nodes might inhibit host immune
response and favors malignant transformation and tumor
progression.
In conclusion, the increase of Tregs in peripheral
blood and tumor-draining lymph nodes of 4NQO-
induced tongue carcinogenesis is correlated with tumor
development. It might stand for an immunosuppressive
mechanism in the pathogenesis of oral cancer. Further
studies are needed to clarify the role and mechanism of
Tregs regulation in the progression of oral cancer. The
current study will provide new insights into the carci-
nogenesis of oral cancer.
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